🔗 Share this article

An underground market for unapproved slimming medications is being driven by social media fitness personalities and sellers on messaging platforms, according to new investigations.

Investigational Treatment Acquiring Popularity Via Social Media

The experimental drug, which is still in research studies, is being advertised by social media influencers for its alleged fat-burning effects. Followers are urged to message these profiles privately for supplier links, while also receiving promotional offers.

Active Trade on Social Networks

Separately, a robust trade exists on Telegram, where groups with thousands of members share “before and after” images, injection guides and claims of rapid UK delivery. Vendors promote the substance there before directing customers to WhatsApp for purchases.

Learning About The Experimental Drug

This medication is an investigational injectable developed by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – GLP-1, GIP and glucagon. Preliminary studies suggest it could assist patients lose up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being hailed online as the next Ozempic.

Medical Professionals Express Concerns

Nevertheless, doctors and pharmacists have warned that the distribution of what remains an unlicensed medication in the UK is a cause for concern and could result in users administering products of uncertain source.

Some professionals said the demand for retatrutide could be linked to the increasing price of approved slimming products such as Mounjaro.

Regulatory Status and Enforcement

Selling retatrutide on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unapproved medication that cannot be marketed or supplied for human use under the British medical regulations.

Several influencers attempt to circumvent the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but promotion and distribution can still breach medicines, advertising, and customer laws, potentially leading to fines, prosecution or imprisonment.

Platform Response and Content Elimination

According to TikTok, the service has taken down problematic content and banned associated keywords and query recommendations. The company stated it was dedicated to maintaining the platform secure and investing in enhancing compliance measures.

Digital Marketplace Activities

Investigations also discovered communities with up to nine thousand participants marketing retatrutide using the platform's built-in search feature, which functions like a online catalog. Entering “retatrutide” instantly displays channels with thousands of users, filled with photos of weight loss, glowing testimonials and detailed instructions for preparing or administering at residence.

After minutes of joining one community, a seller shared contact information, where the majority of purchases take place. The seller provided an guidebook and promised shipping within 48 hours. When asked whether the substance was genuine, one vendor responded: “You can’t be sure.” Another shared a image of a alleged testing documentation. None inquired about weight, medical conditions or previous experience.

Product Details and Pricing

Within these groups, messages display black plastic packages with postal service labels, stating to contain new batches. One communication read: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, prepared at residence with sterile water, or pre-filled injectors usually sold at 160 pounds for 20mg. When asked how much time a pen should last, sellers give contradictory responses ranging from a few weeks to “depends on your body”.

Service Oversight and Safety Measures

A representative for the messaging service said it regularly moderated harmful content on its service including material that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Cautions

“Individuals are injecting substances they cannot confirm. Although the research behind retatrutide is sound, these online products may not contain what they advertise,” said a pharmacy expert, the head of pharmacy at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor connected the surge in interest to recent cost increases for authorized weight-loss drugs such as Mounjaro. “With costs rising, individuals are using online platforms. But counterfeit injections are extremely dangerous. You can’t be certain what’s contained or whether the conditions they were produced in was clean,” she explained.

Her team has already encountered individuals harmed by personal administration from unconfirmed sources. “We understand the frustration, but buying from Telegram or WhatsApp is gambling with your well-being,” said the doctor. “These materials could be impure or incorrectly dosed.”

Producer Statement

A spokesperson from Eli Lilly stated retatrutide was in third stage research studies and had not been reviewed or approved by any regulatory agency anywhere in the world. “Therefore at this point no one can sell [it] for human use,” they said, adding that any item “falsely representing itself as a Lilly experimental substance not yet authorized … may expose users to potentially significant medical dangers”.